PDS Biotechnology: Interim Data Reinforces Push Towards Phase 3 Study (NASDAQ:PDSB)


Scientific Measuring Beakers With Colorful Liquid

gerenme/iStock via Getty Images

PDS Biotechnology Corporation (NASDAQ:PDSB) has been able to make great progress with respect to advancing the use of its lead candidate known as PDS0101, which is being developed in combination with Merck’s (



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *